Policy & Regulation

Maharashtra Signs 15 MoUs at PULSE 2026 — Is India's Biggest State About to Become a Global Healthcare Hub?

By BHC, Editor in Chief · March 31, 2026 · 5 min read

BHC, Editor in Chief — Maharashtra Signs 15 MoUs at PULSE 2026 — Is India's Biggest State About to Become a Global Healthcare Hub?

Summary

  • Maharashtra signed landmark healthcare MoUs at PULSE 2026, including partnerships with UK universities and investments worth ₹720 crore. Here is what the Maharashtra Declaration means for India's healthcare future.

Indian states are increasingly competing on healthcare capacity. And Maharashtra, with the country's largest medical education ecosystem and one of its most concentrated clusters of hospitals, research institutions, and pharmaceutical companies, just made its most ambitious move yet. At PULSE 2026 — a landmark healthcare conclave held in Mumbai on March 27 and 28 — the state signed 15 MoUs covering both investment and strategic partnerships, in the presence of Chief Minister Devendra Fadnavis and State Minister for Medical Education Madhuri Misal.

"PULSE is not just a conclave — we are setting the direction for how healthcare in Maharashtra will evolve over the next decade."

The event brought together more than 130 speakers from government, academia, industry, and multilateral institutions. Its output — the Maharashtra Declaration — is intended to set the direction for the state's healthcare evolution over the next ten years. This is not a roadshow. This is a policy commitment at scale.

**The MoUs: What Was Signed and What It Means

Three of the 15 MoUs were investment agreements totalling ₹720 crore. Nipro Pharmapackaging committed ₹200 crore for direct industrial expansion into Maharashtra. Pharmax committed ₹470 crore and Savvycare ₹50 crore — both tied to Maharashtra's upcoming Bulk Drug Park, a manufacturing cluster being built under a public-private partnership model with MIDC and Ramky Infrastructure.

The remaining 12 were strategic partnerships, and three deserve particular attention. The Royal College of Physicians & Surgeons of Glasgow formalised a long-term academic alliance covering clinical training, research, and innovation hubs — making a Maharashtra medical qualification globally benchmarked by design. The University of Leeds signed a similar framework agreement with the state's medical directorate, MEDD. And Manchester Metropolitan University's Institute of Sport committed to curriculum delivery and Centres of Excellence in sports and exercise medicine.

These are not ceremonial partnerships. They represent a deliberate effort to internationalise Maharashtra's medical education and training — linking the state's 17,000+ medical seats to global institutions and standards.

**Why This Matters for the Broader Ecosystem

Maharashtra runs the largest state medical education ecosystem in India, producing graduates who work across the US, UK, Middle East, and Southeast Asia. PULSE 2026 signals that the state government is now actively working to capture more value from that talent pipeline — through research partnerships, clinical training upgrades, and investment in pharmaceutical manufacturing.

For healthcare founders, the Maharashtra Declaration creates a more structured policy environment for piloting, partnering, and scaling. The Bulk Drug Park signals serious manufacturing ambition. The international academic partnerships signal a commitment to quality standards that will benefit the entire ecosystem.

**BHC Perspective

At Bengaluru Health Community, we pay close attention when states make bold, structured healthcare commitments — because those commitments create real opportunities for startups, hospitals, and professionals. PULSE 2026 is the kind of policy event that healthcare founders should be tracking. The MoUs signed this week will shape tender opportunities, partnership structures, and investment flows in Maharashtra's healthcare sector for years to come. Founders who understand the policy landscape have a head start.

**Frequently Asked Questions

Q: What is PULSE 2026?
A: PULSE 2026 is a healthcare conclave organised by the Government of Maharashtra, bringing together government, academia, industry, and global institutions to set the direction for the state's healthcare evolution over the next decade.

Q: How much investment was committed at PULSE 2026?
A: Three investment MoUs totalling ₹720 crore were signed, including commitments from Nipro Pharmapackaging (₹200 crore), Pharmax (₹470 crore), and Savvycare (₹50 crore).

Q: Which international universities partnered with Maharashtra at PULSE 2026?
A: The Royal College of Physicians & Surgeons of Glasgow, the University of Leeds, and Manchester Metropolitan University's Institute of Sport all signed formal partnership agreements with Maharashtra's medical directorate.